NCER-PD stands for National centre for Excellence in Research on Parkinson’s Disease. It represents a joint effort between 4 partners in Luxembourg that unite their expertise in Parkinson’s disease. This collaboration between all the research institutions focusing on Parkinson’s disease in Luxembourg has been funded by the Fonds National de la Recherche (FNR) since Spring 2015.
The partner institutes are as follows:
|Luxembourg Centre for Systems Biomedicine (LCSB)||Centre Hospitalier de Luxembourg (CHL)|
|Integrated Biobank of Luxembourg (IBBL)||Luxembourg Institute of Health (LIH, former CRP-Santé)|
In addition, the following international partner institutions are involved in the research program:
- Paracelsus Elena Hospital in Kassel: DeNoPa study led by Prof. Britt Mollenhauer
- Hertie Institute for Clinical Brain Research, at the German Centre for Neurodegenerative Diseases (DZNE) at the University of Tübingen: TREND and PMPP cohorts led by Prof. Daniela Berg
- Oxford Parkinson’s disease Center (OPDC) led by Prof. Michele Hu and Prof. Richard Wade-Martins
In order to answer the urgent questions surrounding the occurance of Parkinson’s disease, researchers need to analyse clinical data and samples from hundreds of patients and healthy control persons. The active participation in the Luxembourgish Parkinson’s study is therefore an important prerequisite for the success of the NCER-PD research project.
|NCER-PD is also supported by a Horizon2020 TWINNING-funded project: CENTRE-PD. CENTRE-PD fosters collaboration between three sites: University of Luxembourg (UL), Oxford University (UOXF) and University of Tubingen (EKUT) to help establish a comprehensive clinical centre for diagnosis and treatment of Parkinson’s disease at the University of Luxembourg. The aim is to establish long-lasting collaborations between the three sites on various topics, including Parkinson clinical cohorts, diagnosis, treatment and research.|